Related Experiment Video
Updated: Apr 5, 2026
10:23
Sample Preparation for Endopeptidomic Analysis in Human Cerebrospinal Fluid
Published on: December 4, 2017
9.5K
Neuroproteomic profiling of human body fluids
Anna Häggmark1, Jochen M Schwenk1, Peter Nilsson1
1Affinity Proteomics, SciLifeLab, School of Biotechnology, KTH - Royal Institute of Technology, Stockholm, Sweden.
Proteomics. Clinical Applications
|August 20, 2015
Summary
Neuroproteomics advances disease research by analyzing protein profiles in body fluids. New technologies like mass spectrometry offer deeper insights into neurological disorders beyond traditional biomarkers.
Area of Science:
- Neuroscience
- Biochemistry
- Proteomics
Background:
- Neurological diseases stem from brain dysfunction, but human tissue scarcity necessitates using body fluids like cerebrospinal fluid and blood for research.
- Focusing on a few hallmark proteins has yielded insufficient signatures for fully understanding and predicting disease progression.
- The field of neuroproteomics has emerged to address these limitations.
Purpose of the Study:
- To provide an overview of how advanced proteomic technologies are applied in neurological disease research.
- To discuss key considerations for discovering disease-associated protein profiles.
Main Methods:
- Utilizing affinity proteomics and mass spectrometry for multiplexed and high-throughput protein profiling.
- Analyzing protein expression and abundance in body fluids.
Main Results:
- Advanced proteomic technologies enable broader analysis of disease-associated processes and pathways.
- These methods facilitate the discovery of novel protein signatures for neurological disorders.
Conclusions:
- Neuroproteomics offers a powerful approach to expand knowledge of neurological diseases.
- Technological advancements are crucial for identifying comprehensive disease-associated protein profiles.
Keywords:
Affinity proteomicsBiomarkersBody fluidsMass spectrometryNeurological diseaseNeuroproteomics
